AAAAAA
Results: 1-25/27
Authors:
DOMENGE C
LECESNE A
PAUTIER P
KRAMAR A
LECHEVALIER T
BOUVET N
THILL L
ESCUDIER B
Citation: C. Domenge et al., ALL-TRANS-RETINOIC ACID (ATRA) + - ALPHA-INTERFERON (IFN) IN SQUAMOUS-CELL CARCINOMA (SCC) - A RANDOMIZED PHASE-II STUDY/, Annals of oncology, 9, 1998, pp. 623-623
Authors:
RIXE O
GATINEAU M
BATOUCHE M
RAYMOND E
DOMENGE C
JANOT F
SCHWAAB G
LUBOINSKI B
ARMAND JP
Citation: O. Rixe et al., SEQUENTIAL NEOADJUVANT CHEMOTHERAPY (SC) FOR HEAD AND NECK SQUAMOUS-CELL CARCINOMA (HNSCC), Annals of oncology, 9, 1998, pp. 672-672
Authors:
DECREVOISIER R
BOURHIS J
DOMENGE C
WIBAULT P
KOSCIELNY S
LUSINCHI A
MAMELLE G
JANOT F
JULIERON M
LERIDANT AM
MARANDAS P
ARMAND JP
SCHWAAB G
LUBOINSKI B
ESCHWEGE F
Citation: R. Decrevoisier et al., FULL-DOSE REIRRADIATION FOR UNRESECTABLE HEAD AND NECK-CARCINOMA - EXPERIENCE AT THE GUSTAVE-ROUSSY-INSTITUTE IN A SERIES OF 169 PATIENTS, Journal of clinical oncology, 16(11), 1998, pp. 3556-3562
Authors:
MASSAADMASSADE L
DOMENGE C
RONGEAT S
HASSOUN L
LEGROS MH
ROPERS J
JANOT F
PARISE O
GOUYETTE A
Citation: L. Massaadmassade et al., RED-BLOOD-CELL GLUTATHIONE LEVELS BEFORE AND DURING TREATMENT WITH NEOADJUVANT CHEMOTHERAPY CISPLATIN 5-FLUOROURACIL IN PATIENTS WITH HEAD AND NECK SQUAMOUS-CELL CARCINOMA/, Anticancer research, 18(1A), 1998, pp. 283-288
Authors:
SALVAN D
JULIERON M
MARANDAS P
JANOT F
LERIDANT AM
DOMENGE C
MAMELLE G
SCHWAAB G
LUBOINSKI B
Citation: D. Salvan et al., COMBINED TRANSFACIAL AND NEUROSURGICAL APPROACH TO MALIGNANT-TUMORS OF THE ETHMOID SINUS, Journal of Laryngology and Otology, 112(5), 1998, pp. 446-450
Authors:
MIR LM
GLASS LF
SERSA G
TEISSIE J
DOMENGE C
MIKLAVCIC D
JAROSZESKI MJ
ORLOWSKI S
REINTGEN DS
RUDOLF Z
BELEHRADEK M
GILBERT R
ROLS MP
BELEHRADEK J
BACHAUD JM
DECONTI R
STABUC B
CEMAZAR M
CONINX P
HELLER R
Citation: Lm. Mir et al., EFFECTIVE TREATMENT OF CUTANEOUS AND SUBCUTANEOUS MALIGNANT-TUMORS BYELECTROCHEMOTHERAPY, British Journal of Cancer, 77(12), 1998, pp. 2336-2342
Authors:
DOMENGE C
BATOUCHE M
BELLAMY J
DARTEVELLE P
JANOT F
MARANDAS P
LUBOINSKI B
Citation: C. Domenge et al., RESECTION OF LUNG NEOPLASTIC NODULES LONG-TERM BENEFIT SURVIVAL FROM HEAD AND NECK-CANCER PATIENTS, British Journal of Cancer, 77, 1998, pp. 148-148
Authors:
KATCHMAR TB
BILYNSKY BT
DOMENGE C
KRAMAR A
SHPARIK J
Citation: Tb. Katchmar et al., NEOADJUVANT CHEMOTHERAPY BEFORE RADIOTHERAPY OF ADVANCED HEAD AND NECK-CANCER IN UKRAINE, European journal of cancer, 33, 1997, pp. 858-858
Authors:
PIGNON JP
DESIGNE L
BOURHIS J
DOMENGE C
GUERIN S
LUBOINSKI M
Citation: Jp. Pignon et al., CHEMOTHERAPY IN LOCALLY ADVANCED HEAD AND NECK SQUAMOUS-CELL CARCINOMA (HNSCC) - PRELIMINARY-RESULTS OF A METAANALYSIS USING INDIVIDUAL PATIENT DATA OF RANDOMIZED TRIALS, European journal of cancer, 33, 1997, pp. 1309-1309
Authors:
KAMBOUCHNER M
COLBY TV
DOMENGE C
BATTESTI JP
SOLER P
TAZI A
Citation: M. Kambouchner et al., ERDHEIM-CHESTER-DISEASE WITH PROMINENT PULMONARY INVOLVEMENT ASSOCIATED WITH EOSINOPHILIC GRANULOMA OF MANDIBULAR BONE, Histopathology, 30(4), 1997, pp. 353-358
Authors:
BOLLA M
LAPLANCHE A
LEFUR R
VAN JT
DOMENGE C
LEFEBVRE JL
LUBOINSKI B
Citation: M. Bolla et al., PREVENTION OF 2ND PRIMARY TUMORS WITH A 2ND-GENERATION RETINOID IN SQUAMOUS-CELL CARCINOMA OF ORAL CAVITY AND OROPHARYNX - LONG-TERM FOLLOW-UP, European journal of cancer, 32A(2), 1996, pp. 375-376
Authors:
WIBAULT P
BENSMAINE MEA
DEFORNI M
ARMAND JP
BERNAL ET
GUILLOT T
RECONDO G
DOMENGE C
JANOT F
BOREL C
LUBOINSKI B
ESCHWEGE F
CVITKOVIC E
Citation: P. Wibault et al., INTENSIVE CONCOMITANT CHEMORADIOTHERAPY IN LOCALLY ADVANCED UNRESECTABLE SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK - A PHASE-II STUDY OFRADIOTHERAPY WITH CISPLATIN AND 7-WEEK CONTINUOUS INFUSIONAL FLUOROURACIL, Journal of clinical oncology, 14(4), 1996, pp. 1192-1200
Authors:
BENSMAINE MEA
GUILLOT T
BERNAL ET
JANOT F
SIGAL R
DOMENGE C
WIBAULT P
ARMAND JP
CVITKOVIC E
Citation: Mea. Bensmaine et al., NEOADJUVANT CHEMOTHERAPY WITH CISPLATIN-VINDESINE-5-FLUOSOURACIL AND FOLINIC ACID FOR LOCALLY ADVANCED HEAD AND NECK-CARCINOMA, American journal of clinical oncology, 19(4), 1996, pp. 356-362
Authors:
BENSMAINE MEA
AZLI N
DOMENGE C
ARMAND JP
CVITKOVIC E
Citation: Mea. Bensmaine et al., PHASE I-II TRIAL OF RECOMBINANT INTERFERON-ALPHA-2B WITH CISPLATIN AND 5-FLUOROURACIL IN RECURRENT AND OR METASTATIC CARCINOMA OF HEAD AND NECK/, American journal of clinical oncology, 19(3), 1996, pp. 249-254
Authors:
DOMENGE C
ORLOWSKI S
LUBOINSKI B
DEBAERE T
SCHWAAB G
BELEHRADEK J
MIR LM
Citation: C. Domenge et al., ANTITUMOR ELECTROCHEMOTHERAPY - NEW ADVANCES IN THE CLINICAL PROTOCOL, Cancer, 77(5), 1996, pp. 956-963
Authors:
CAPPELAERE P
FOURNIER C
ROLLAND F
MEEUS L
DOMENGE C
KRAKOWSKI I
DEGISLAIN C
CHAUVERGNE J
DUFOURESQUERRE F
PION JM
HECQUET B
Citation: P. Cappelaere et al., PREDICTIVE VALUE OF HEMATOLOGICAL COUNTS AT THE 4TH DAY AFTER CARBOPLATIN-FLUOROURACIL REGIMEN FOR NEUTRO AND OR THROMBOPENIA/, Bulletin du cancer, 83(7), 1996, pp. 559-565
Authors:
BOLLA M
LEFUR R
VAN JT
DOMENGE C
BADET JM
LAPLANCHE A
Citation: M. Bolla et al., PREVENTION OF SECOND PRIMARY TUMORS WITH A 2ND-GENERATION RETINOID INSQUAMOUS-CELL CARCINOMA OF ORAL CAVITY AND OROPHARYNX - LONG-TERM FOLLOW-UP, European journal of cancer, 31A, 1995, pp. 386-386
Authors:
DOMENGE C
LANCAR R
COCHEDEQUEANT B
LUSINCHI A
LEFEBVRE JL
MARANDAS P
ESCHWEGE F
SANCHOGAMIER H
LUBOINSKI B
Citation: C. Domenge et al., INDUCTION CHEMOTHERAPY BEFORE RADIOTHERAPY IN OROPHARYNGEAL CARCINOMA- A RANDOMIZED TRIAL, European journal of cancer, 31A, 1995, pp. 393-393
Authors:
DOMENGE C
MASSADE L
RONGEAT S
HASSOUN L
LEGROS MH
JANOT F
JULIERON M
LUBOINSKI B
GOUYETTE A
Citation: C. Domenge et al., GLUTATHIONE SYSTEM AND CHEMORESPONSE TO 5-FLUOROURACIL AND CISPLATINEIN HEAD AND NECK SQUAMOUS-CELL CARCINOMA - A PILOT-STUDY, European journal of cancer, 31A, 1995, pp. 402-402
Authors:
BOURHIS J
FORTIN A
DUPUIS O
DOMENGE C
LUSINCHI A
MARANDAS P
SCHWAAB G
ARMAND JP
LUBOINSKI B
MALAISE E
ESCHWEGE F
WIBAULT P
Citation: J. Bourhis et al., VERY ACCELERATED RADIATION-THERAPY - PRELIMINARY-RESULTS IN LOCALLY UNRESECTABLE HEAD AND NECK CARCINOMAS, International journal of radiation oncology, biology, physics, 32(3), 1995, pp. 747-752
Authors:
CAPPELAERE P
HECQUET B
ROLLAND F
MEEUS L
DOMENGE C
KRAKOWSKI I
DEGISLAIN C
CHAUVERGNE J
DUFOURESQUERRE F
CARDE P
Citation: P. Cappelaere et al., RANDOMIZED TRIAL OF MYELOPREVENTION BY GORALATINE VS PLACEBO FOR PATIENTS WITH HEAD AND NECK SQUAMOUS-CELL CARCINOMA, TREATED BY CARBOPLATIN-FLUOROUROCILE, Bulletin du cancer, 82(9), 1995, pp. 732-737
Authors:
DEGARDIN M
DOMENGE C
CAPPELAERE P
LUBOINSKI B
NAVARRETE MS
SCOTT JE
LEFEBVRE JL
Citation: M. Degardin et al., A PHASE-II STUDY OF PIRITREXIM IN PATIENTS WITH ADVANCED SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK, European journal of cancer, 30A(7), 1994, pp. 1044-1045
Authors:
BOLLA M
LEFUR R
VAN JT
DOMENGE C
BADET JM
KOSKAS Y
LAPLANCHE A
Citation: M. Bolla et al., PREVENTION OF 2ND PRIMARY TUMORS WITH ETRETINATE IN SQUAMOUS-CELL CARCINOMA OF THE ORAL CAVITY AND OROPHARYNX - RESULTS OF A MULTICENTRIC DOUBLE-BLIND RANDOMIZED STUDY, European journal of cancer, 30A(6), 1994, pp. 767-772
Authors:
CVITKOVIC E
DOMENGE C
GANDIA D
Citation: E. Cvitkovic et al., CASE-REPORT OF ACQUIRED PIRITREXIM RESISTANCE AND COLLATERAL METHOTREXATE SENSITIVITY IN RECURRENT SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK, Journal of the National Cancer Institute, 85(15), 1993, pp. 1248-1248
Authors:
DEFORNI M
CHABOT GG
ARMAND JP
FONTANA X
RECONDO G
DOMENGE C
CARDE P
BARBU M
GOUYETTE A
Citation: M. Deforni et al., PHASE-I AND PHARMACOKINETIC STUDY OF BREQUINAR (DUP-785 NSC-368390) IN CANCER-PATIENTS, European journal of cancer, 29A(7), 1993, pp. 983-988